We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+9.85%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.13B
AUM Growth
+$72.2M
Cap. Flow
+$9.62M
Cap. Flow %
0.85%
Top 10 Hldgs %
7.17%
Holding
858
New
204
Increased
192
Reduced
260
Closed
148

Top Buys

Rank Stock Value
1
WMB icon
Williams Companies
WMB
+$4.82M
2
VFC icon
VF Corp
VFC
+$4.71M
3
INSP icon
Inspire Medical Systems
INSP
+$4.06M
4
GLW icon
Corning
GLW
+$3.96M
5
PCRX icon
Pacira BioSciences
PCRX
+$3.94M

Top Sells

Rank Stock Value
1
SPOT icon
Spotify
SPOT
+$7.22M
2
UBER icon
Uber
UBER
+$5.67M
3
TEAM icon
Atlassian
TEAM
+$5.66M
4
HOOD icon
Robinhood
HOOD
+$5.36M
5
NTLA icon
Intellia Therapeutics
NTLA
+$4.9M

Sector Composition

Rank Sector Weight
1 Healthcare 20.98%
2 Technology 20.39%
3 Industrials 14.03%
4 Consumer Discretionary 11.34%
5 Financials 10.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KVYO icon
226
Klaviyo
KVYO
$5.73B
$1.84M 0.16%
52,098
-7,500
-13% -$217K
AVDX
227
DELISTED
AvidXchange
AVDX
$1.84M 0.16%
+226,373
New +$2.13M
CWEN icon
228
Clearway Energy Class C
CWEN
$4.89B
$1.83M 0.16%
59,791
+14,058
+31% +$388K
ALAB icon
229
Astera Labs
ALAB
$45.3B
$1.83M 0.16%
+35,000
New +$1.64M
HAPN
230
Happen Inc
HAPN
$2.16B
$1.83M 0.16%
160,127
+36
+0% +$384
CRL icon
231
Charles River Laboratories
CRL
$11.6B
$1.82M 0.16%
9,263
-3,500
-27% -$727K
MWA icon
232
Mueller Water Products
MWA
$4.03B
$1.81M 0.16%
+83,385
New +$1.68M
VREX icon
233
Varex Imaging
VREX
$464M
$1.8M 0.16%
+151,211
New +$1.93M
UHS icon
234
Universal Health Services
UHS
$10B
$1.8M 0.16%
7,842
HBM icon
235
Hudbay
HBM
$9.7B
$1.79M 0.16%
194,382
+47,155
+32% +$380K
RNAM
236
DELISTED
Avidity Biosciences
RNAM
$1.78M 0.16%
38,846
-9
-0% -$391
HCP
237
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$1.78M 0.16%
52,605
-36,379
-41% -$1.23M
GILD icon
238
Gilead Sciences
GILD
$166B
$1.77M 0.16%
+21,107
New +$1.61M
NVCR icon
239
NovoCure
NVCR
$1.85B
$1.75M 0.16%
112,083
-76,339
-41% -$1.38M
MRSH
240
Marsh
MRSH
$92.1B
$1.75M 0.16%
7,850
-33
-0.4% -$7.33K
ICUI icon
241
ICU Medical
ICUI
$4.21B
$1.75M 0.16%
9,610
+1
+0% +$148
EPAC icon
242
Enerpac Tool Group
EPAC
$1.86B
$1.75M 0.16%
41,797
-75
-0.2% -$3.01K
ARCT icon
243
Arcturus Therapeutics
ARCT
$165M
$1.74M 0.15%
+75,144
New +$1.61M
REPL icon
244
Replimune Group
REPL
$425M
$1.74M 0.15%
158,770
ABT icon
245
Abbott
ABT
$189B
$1.73M 0.15%
15,200
-8,500
-36% -$932K
HLT icon
246
Hilton Worldwide
HLT
$72.4B
$1.73M 0.15%
7,501
+99
+1% +$21.4K
LEVI icon
247
Levi Strauss
LEVI
$9.68B
$1.73M 0.15%
79,243
+129
+0.2% +$2.44K
JKHY icon
248
Jack Henry & Associates
JKHY
$11.4B
$1.72M 0.15%
+9,762
New +$1.65M
NBIX icon
249
Neurocrine Biosciences
NBIX
$18.3B
$1.72M 0.15%
+14,900
New +$2.04M
BN icon
250
Brookfield
BN
$103B
$1.72M 0.15%
48,450
-32,345
-40% -$1.02M

Similar funds

PDT Partners's Q3 2024 Portfolio in Review

As of Q3 2024, PDT Partners held 858 positions worth $1.13B, up 6.8% from $1.06B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.

PDT Partners's Q3 2024 filing shows 204 new, 192 increased, 260 reduced and 148 closed positions. Its largest new stake was Williams Companies: 109,577 shares worth $5M. The largest sale was Spotify, an estimated $7.22M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.

  • PDT Partners's largest Q3 2024 buy was Williams Companies: 109,577 shares worth $5M.
  • PDT Partners added most to e.l.f. Beauty in Q3 2024, an estimated $3.84M increase.
  • PDT Partners's biggest Q3 2024 reduction was Spotify, cutting an estimated $7.22M.
  • PDT Partners fully exited Atlassian in Q3 2024, selling an estimated $5.66M.
  • PDT Partners's ten largest holdings make up 7.2% of its $1.13B portfolio in Q3 2024.
  • PDT Partners opened 204 new positions and closed 148 in Q3 2024.
  • PDT Partners's portfolio value rose 6.8% quarter-over-quarter to $1.13B.

Based on PDT Partners's 13F filing for Q3 2024, filed 14 Nov 2024.